NURO
Price:
$4.58
Market Cap:
$9.43M
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. Neuro...[Read more]
Industry
Medical - Devices
IPO Date
2004-07-22
Stock Exchange
NASDAQ
Ticker
NURO
According to NeuroMetrix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.16. This represents a change of 7.43% compared to the average of -1.08 of the last 4 quarters.
The mean historical PE Ratio of NeuroMetrix, Inc. over the last ten years is 182.47. The current -1.16 PE Ratio has changed -163.39% with respect to the historical average. Over the past ten years (40 quarters), NURO's PE Ratio was at its highest in in the June 2018 quarter at 33.46. The PE Ratio was at its lowest in in the March 2021 quarter at -433.06.
Average
182.47
Median
-2.55
Minimum
-47.82
Maximum
1.95K
Discovering the peaks and valleys of NeuroMetrix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 326.97%
Maximum Annual PE Ratio = 1.95K
Minimum Annual Increase = -106359.95%
Minimum Annual PE Ratio = -47.82
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.00 | 74.49% |
| 2023 | -0.57 | -76.40% |
| 2022 | -2.43 | -94.79% |
| 2021 | -46.72 | -2.30% |
| 2020 | -47.82 | 326.97% |
| 2019 | -11.20 | -100.58% |
| 2018 | 1.95K | -106359.95% |
| 2017 | -1.83 | -31.09% |
| 2016 | -2.66 | -61.91% |
| 2015 | -6.98 | -57.39% |
The current PE Ratio of NeuroMetrix, Inc. (NURO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.34
5-year avg
-19.71
10-year avg
182.47
NeuroMetrix, Inc.’s PE Ratio is greater than QT Imaging Holdings, Inc. (-3.85), less than Field Trip Health Ltd. (-0.14), less than ProSomnus, Inc. (-0.32), less than Centogene N.V. (-0.22), less than China Jo-Jo Drugstores, Inc. (0.00), less than ETAO International Co., Ltd. (-0.00), less than Apexigen, Inc. (-0.24), less than IMV Inc. (-0.18), greater than CervoMed Inc. (-1.30), less than TNF Pharmaceuticals, Inc. (-0.19),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.85 | $100.40M | |
| -0.14 | $9.81M | |
| -0.32 | $8.18M | |
| -0.22 | $9.42M | |
| 0.00 | $9.95M | |
| -0.00 | $9.78M | |
| -0.24 | $9.57M | |
| -0.18 | $23.42K | |
| -1.30 | $39.26M | |
| -0.19 | $9.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroMetrix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroMetrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeuroMetrix, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeuroMetrix, Inc. (NURO)?
What is the highest PE Ratio for NeuroMetrix, Inc. (NURO)?
What is the 3-year average PE Ratio for NeuroMetrix, Inc. (NURO)?
What is the 5-year average PE Ratio for NeuroMetrix, Inc. (NURO)?
How does the current PE Ratio for NeuroMetrix, Inc. (NURO) compare to its historical average?